American firearms manufacturer Smith & Wesson (NASDAQ:SWBI) missed analysts’ expectations in Q2 CY2024, with revenue down 22.7% year on year to $88.33 million. It made a GAAP loss of $0.05 per share, down from its profit of $0.07 per share in the same quarter last year.
Is now the time to buy Smith & Wesson? Find out in our full research report.
Smith & Wesson (SWBI) Q2 CY2024 Highlights:
-
Revenue: $88.33 million vs analyst estimates of $102.5 million (13.8% miss)
-
EPS: -$0.05 vs analyst estimates of -$0.02 (-$0.03 miss)
-
Gross Margin (GAAP): 27.4%, in line with the same quarter last year
-
EBITDA Margin: 11.2%
-
Free Cash Flow Margin: -40.2%
-
Market Capitalization: $642.4 million
Mark Smith, President and Chief Executive Officer, commented, “Overall firearms demand during our first fiscal quarter was softer than we anticipated, but our results once again…
